Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q4 2025 holdings

Shares (Q4 2025)
804,084
Value
$14.6M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of AVTX by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 2025804,084$14.6M<0.1%+111,447+16.1%AddedHolders
Q3 2025692,637$8.80M<0.1%+525,696+314.9%AddedHolders
Q2 2025166,941$833.0K<0.1%00.0%UnchangedHolders
Q1 2025166,941$1.34M<0.1%+1,140+0.7%AddedHolders
Q4 2024165,801$1.23M<0.1%+155,433+1,499.2%AddedHolders
Q3 202410,368$98.1K<0.1%00.0%UnchangedHolders
Q2 202410,368$129.3K<0.1%+10,368NewHolders
Q4 20230$00.0%−91,817−100.0%Sold outHolders
Q3 202391,817$11.1K<0.1%−130,256−58.7%ReducedHolders
Q2 2023222,073$78.9K<0.1%00.0%UnchangedHolders
Q1 2023222,073$388.6K<0.1%00.0%UnchangedHolders
Q4 2022222,073$1.12M<0.1%+910.0%AddedHolders
Q3 2022221,982$736.0K<0.1%−33,897−13.2%ReducedConverted for a 1-for-12 splitHolders
Q2 20223,070,553$1.53M<0.1%−313,641−9.3%ReducedHolders
Q1 20223,384,194$2.45M<0.1%+4,891+0.1%AddedHolders
Q4 20213,379,303$5.74M<0.1%+32,027+1.0%AddedHolders
Q3 20213,347,276$7.30M<0.1%+147,067+4.6%AddedHolders
Q2 20213,200,209$10.5M<0.1%+511,169+19.0%AddedHolders
Q1 20212,689,040$8.12M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.